PX-866 with Cetuximab (Erbitux) going into Phase Two
coloCan
Member Posts: 1,944 Member
"PX-866 is a pan inhibitor of the PI-3K/PTEN/AKT pathway, a critical cell signalling that is activated in many types of cancer"-(CRC being one of them)
Its made by Oncothyreon Inc and I read about it at prenewswire.com
with an upcoming meeting of ASCO expect more in the news as drug manufacturers generally present their latest stuff at such conventions
Its made by Oncothyreon Inc and I read about it at prenewswire.com
with an upcoming meeting of ASCO expect more in the news as drug manufacturers generally present their latest stuff at such conventions
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 122K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 673 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 238 Multiple Myeloma
- 7.2K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 543 Sarcoma
- 736 Skin Cancer
- 657 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards